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Studies in somatic cells have shown that glucocorticoids such as dexamethasone (DEX)
may trigger or prevent apoptosis depending on the cell type in culture. Because the
dysregulation of apoptosis may lower in vitro embryo production efﬁciency, we sought to
investigate the effects of supplementing IVC medium with DEX (0.1 mg/mL) on embryo
morphology, development kinetics, and apoptosis rates of in vitro–produced bovine
preimplantation embryos. Embryo morphology was graded on Day 7, and development
rates were assessed on Days 4 and 7 of IVC. Apoptosis was evaluated via annexin/pro-
pidium iodide staining under ﬂuorescence microscopy where a cell labeled with annexin,
propidium iodide, or both would be considered apoptotic. An embryo was counted in the
apoptosis rates, if it displayed at least one such labeled cell. Although DEX supplemen-
tation did not reduce apoptosis rates, it had a positive impact on developmental kinetics
and cell number both on Days 4 and 7 of embryo culture. Presumably, such effect resulted
from increased cell proliferation rather than a direct inhibition of apoptosis. Further
studies may evaluate the mechanisms by which glucocorticoids may affect embryo
development, as DEX supplementation could become a tool to improve in vitro embryo
yield in mammalian species.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Although the onset of programmed cell death or
apoptosis is a physiological event playing a role in cell
selection in preimplantation mammalian embryos [1,2],
the regulation of this process may be altered in in vitro–
production systems. For instance, the percent of apoptotic
cells was higher in in vitro than in vivo–derived bovine
blastocysts suggesting a negative effect of gamete manip-
ulation and/or culture conditions on embryo health [3,4].
Moreover, in vitro conditions predisposing to embryo3.
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17apoptosis also gave rise to defective mouse embryos that
failed to develop normally after transfer [5]. This could be
particularly relevant in livestock species when dealing
with valuable embryos or those resulting from SCNT. In
fact, SCNT-derived embryos may be particularly predis-
posed to undergoing apoptosis, thus further lowering the
efﬁciency of this technology [6–8] Apoptosis in in vitro–
production systems is likely caused, at least partially,
by suboptimal culture conditions, resulting in embryos
that often display abnormal or delayed cleavage, ultimately
affecting the percent and quality of the blastocysts
produced [2,9–11]. Hence, media additives inhibiting
apoptosis could have an important positive impact in
in vitro embryo production rates.
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compounds affecting a wide array of metabolic functions
exerted both via the genomic regulation of cellular meta-
bolism [12] and cell cycle [13], and through nongenomic
effects on cell metabolism and signaling (reviewed by [14]).
Dexamethasone (DEX), is a synthetic GC that via its effects
on cell-to-cell contact and signaling pathways prevented
apoptosis in bovine granulosa cells [15–18] and in human
lung epithelial cells [19], mammary epithelial cells [20], and
hepatocytes [21]. Conversely, however, DEX also stimulated
apoptosis in thymocytes and lymphocytes, an effect that
correlated with the expression of an intracellular gluco-
corticoid receptor [14,22]. Although there is evidence for
GCs inhibiting apoptosis through both genomic and non-
genomic pathways, the mechanisms are still unclear [23].
For instance, some studies have addressed the correlation
between the expression of Bcl-2 antiapoptotic proteins and
cell sensitivity to GC-induced apoptosis [21,24,25]; in this
regard, DEX differentially regulated Bcl-2 transcription
levels in human neutrophils and eosinophils, resulting in a
delay and acceleration of apoptosis, respectively [26].
Interestingly, however, DEX activated survival pathways in
bovine granulosa cells via Mitogen-activated protein kinase
and Protein Kinase B (Akt/PKB) phosphorylation, suggest-
ing a nongenomic-driven effect of GCs mediated through
their interactionwith a putative membrane bound receptor
[15]. Conversely, DEX-mediated MAPK pathway down-
regulation induced apoptosis in multiple myeloma cells
[27]. Altogether, these studies suggest that the dichotomy
observed with GCs in regards to the induction or preven-
tion of apoptosis may depend partially on cell type, and on
GC receptor or apoptotic gene expression, and/or pro-
survival signaling pathway activity in the particular cell
population under study, among other factors, given the
widespread range of effects known to be exerted by GCs
both in vivo and in vitro [23].
Given the above premises, the aim of this study was to
investigate the effects of DEX addition during IVC of bovine
embryos, and in particular in regards to its ability to
modulate apoptosis.
2. Materials and methods
2.1. Reagents
Unless otherwise stated, all chemicals were purchased
from Sigma-Aldrich Chemical Company (St. Louis, MO,
USA).
2.2. In vitro embryo production
Cumulus-oocyte complexes (COCs) were recovered
from small antral follicles (2–8 mm) by follicular aspira-
tion of abattoir ovaries. Compact COCs showing at least
two layers of cumulus cells and a homogenous and
refringent cytoplasm were selected for IVM [28]. The IVM
medium was Tissue culture medium 199 supplemented
with 2.2 g/L sodium bicarbonate, 10% Fetal bovine serum
(Gibco BRL, Grand Island, NY, USA), 0.5 mg/mL FSH
(Folltropin; Bioniche Animal Health, Belleville, Ontario,
Canada), and 5.0 mg/mL LH (Lutropin; Bioniche AnimalHealth). The COCs were incubated for 18 hours under 5%
CO2 in humidiﬁed air at 38.5 C.
Frozen-thawed bull semen (Bos taurus taurus) was pre-
pared for IVF by Percoll (GE Healthcare Bio-Sciences,
Uppsala, Sweden) density gradient centrifugation at
180 g for 7 minutes. For IVF, 2  106 spermatozoa per mL
and 20 oocytes were coincubated for 27 hours in 80-mL
droplets of a modiﬁed Fert-Tyrode’s albumin lactate
pyruvate medium [29] supplemented with 30 mg/mL hep-
arin, 1.8 mM epinephrine, 18 mM penicillamine, 10 mM
hypotaurine, and 4 mg/mL BSA. After IVF, groups of 20
presumptive zygotes were transferred to 100-mL droplets of
modiﬁed synthetic oviductal ﬂuid medium as previously
described [30]. IVF was followed by 7 days of IVC with no
replacement ofmediumduring this period. Both IVFand IVC
were performed under 5% CO2 in humidiﬁed air at 38.5 C.
2.3. Dexamethasone treatment dose titration
Three concentrations of DEX (0.01, 0.1, and 1 mg/mL)
were initially evaluated for their effect in IVC of bovine
embryos. For this purpose, DEX was diluted in distilled
sterile water to make a 10 mM stock solution (following
manufacturer’s recommendations) that then was further
diluted to obtain the ﬁnal concentrations tested. Blastocyst
rates, total cell number, and embryo quality were end
points evaluated on Day 7 of culture.
On Day 7 of culture, embryos were assessed for
morphologic quality using the criteria established by
Stringfellow and Seidel [31]. Thus, grade 1 or very good
quality embryos had an inner cell mass (ICM) with sym-
metrical or few very slightly asymmetrical blastomeres,
that displayed a light appearance. Grade 2 or fair quality
embryos had an ICM with very slightly asymmetrical
blastomeres. And, grade 3 or poor quality embryos had an
ICM that displayed widespread marked asymmetry with a
darker appearance. Grade 1 and 2 embryos were pooled for
analysis herein based on previous evidence that embryos in
both categories yield signiﬁcantly high pregnancy rates,
and are preferentially selected for transfer, whereas grade 3
embryos typically yield low pregnancy rates and thus are
not preferentially selected for transfer [32].
2.4. Experiment I: Effect of DEX on embryo development and
quality
Cleavage and blastocyst rates were evaluated on Days 4
and 7 of IVC, respectively (the fertilization day was set as
Day 0). Blastocysts were classiﬁed as early, expanded, or
hatched [31]. After evaluation, embryos were ﬁxed in 1%
formol-saline solution and stained with the DNA dye
Hoechst 33342 (5 mg/mL) in PBS. Total cell number was
counted using an inverted ﬂuorescence microscope
(Eclipse TE 300; Nikon Instruments Inc., Melville, NY, USA).
2.5. Experiment II: Morphology assessment and analysis of
apoptosis in early embryos treated with DEX
On Day 4, embryos were evaluated for cleavage using
phase contrast inverted microscopy and classiﬁed as slow
(up to 12 blastomeres) or fast cleaving (more than 13
Table 2
Quality grading of bovine blastocysts cultured in the presence of three
concentrations of dexamethasone.
Group Embryo quality (%; mean  SEM)
Grade 3 Grade 2/1
Control 74.9  1.8a,d 25.0  1.8a,e
0.01 mg/mL 80.6  1.5a,d 19.4  1.5a,e
0.1 mg/mL 46.0  3.1b,d 53.9  3.1b,e
1 mg/mL 60.5  2.6c,d 39.5  2.6c,e
The results are the average of at least ﬁve independent experiments.
a,b,c Different superscript letters denote signiﬁcant differences (P  0.05)
within column.
d,e Different superscript letters denote signiﬁcant differences (P < 0.05)
within row.
Abbreviation: SEM, standard error of the mean.
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tion of embryos as slow or fast cleaving was based on data
reported by Leidenfrost, et al. [33] regarding the develop-
ment kinetics of early bovine embryos.
Immediately after morphologic assessment, embryos
were stained using an annexin V/propidium iodide (PI)
assay (Molecular Probes, Inc., Eugene,OR,USA) for apoptosis
analysis, following the manufacturer’s instructions. Brieﬂy,
embryos were rinsed in 1X binding buffer and incubated
with annexin V (Fluorescein isothiocyanate-labeled) for
15 minutes at 4 C. Embryos were incubated with the PI
solution for another 15 minutes at 4 C, then stained with
Hoechst 33342 (5 mg/mL), and mounted on slides for eval-
uation under ﬂuorescence microscopy (Olympus BX41;
OlympusAmerica Inc.,Melville, NY,USA). The embryoswere
classiﬁed as apoptotic or nonapoptotic. Hence, if an embryo
had one or more apoptotic blastomeres, it was considered
apoptotic according to the criteria proposed by Matwee,
et al. [34] and hence counted within our apoptotic rates’
category. Apoptotic blastomeres would be those stained
positive for annexin V, PI, or both annexin and PI. Only un-
stained embryos were included in the nonapoptotic
category.
2.6. Statistical analysis
Data for cleavage and blastocyst rates and for total cell
number were analyzed using ANOVA and Tukey or Stu-
dent–Newman–Keuls’ post hoc tests when required. Data
for morphologic assessment and apoptosis evaluation on
Day 4 of IVC were analyzed using the c2 test. Apoptotic
rates were based on the number of embryos showing at
least one apoptotic cell. All analyses were performed with
SigmaPlot 11.0 software (Systat Software, Inc., Erkrath,
Germany) [35]. A P-value of 0.05 or less denoted
signiﬁcance.
3. Results
3.1. DEX treatment: A dose-response titration experiment
As compared with the untreated control, DEX treatment
had no effect (P > 0.05) on bovine embryo cleavage or
blastocyst rates (Table 1). However, culture in the presence
of 0.1 mg/mL DEX yielded the highest percent (53.9%;
P  0.05) of good quality embryos (Table 2). Based on these
results, 0.1 mg/mL DEX was chosen for further experiments.Table 1
Development rates of in vitro–produced bovine embryos cultured in the
presence of three concentrations of dexamethasone.
Group Oocytes (n) Development rates
(%; mean  SEM)
Cleavagea Blastocysta
Control 119 88.1  4.3 50.8  4.1
0.01 mg/mL 122 89.4  2.6 46.7  3.6
0.1 mg/mL 121 83.2  4.0 49.8  2.9
1 mg/mL 113 85.4  2.7 43.0  3.2
The results are average of at least ﬁve independent experiments.
Abbreviation: SEM, standard error of the mean.
a Rates based on total oocyte number.3.2. Experiment I: Effect of DEX on embryo development and
quality
We next sought to analyze the effect of embryo culture
in the presence of 0.1 mg/mL DEX on the kinetics of blas-
tocyst development. Treatment with DEX yielded similar
percentages of early, expanded, and hatched blastocysts
than those observed in the untreated group (P > 0.05).
Notably, embryo culture in the presence of DEX did result
in expanded and hatched blastocysts presenting higher cell
numbers (P  0.05; Table 3), consistent with a positive ef-
fect on development.
3.3. Experiment II: Effect of DEX on the morphology and
apoptosis rates of Day 4 (early) embryos
To ascertain whether the positive effects of DEX on cell
number related to its ability to prevent apoptosis, we next
evaluated cleavage kinetics and apoptosis rates in early
(Day 4) embryos. Thus, IVC in DEX-containing medium
yielded a higher percentage of fast-cleaving embryos as
compared with the control group (64.3% vs. 23.8%,
respectively; P < 0.05; Fig. 1).
We then analyzed apoptosis rates thus comparing the
percentages of slow- and fast-cleaving embryos between
DEX-treated and untreated groups (Table 4). Interestingly,
the percent of apoptotic embryos was exactly the same in
both experimental groups (28%). Similarly, no differences in
apoptosis rates were detected within morphologic groups
(slow- or fast-cleaving embryos). Additionally, the number
of apoptotic cells per embryo was similar between treated
and untreated groups, for both slow- (1.1–1.5 cells) and
fast-cleaving embryos (2 cells; Table 5). Shown in Figure 2
are representative images of early bovine embryos classi-
ﬁed as fast-cleaving and apoptotic (Fig. 2A, B, E and F) or not
apoptotic (Fig. 2C and D), for each of the experimental
groups.
4. Discussion
In vitro–produced embryos undergo apoptosis at higher
rates than their in vivo–produced counterparts [7,36], thus
negatively affecting the success rates in in vitro livestock
production systems. Given that the occurrence of apoptosis
in in vitro–produced embryos appears to be strongly
Table 3
Effect of IVC in the presence of 0.1 mg/mL of dexamethasone (DEX) on Day-7 bovine embryo quality.
Group Blastocysts (%; mean  SEM) Total cell number (%; mean  SEM)
Earlye Expandede Hatchede Totalf n (%) Early Expanded Hatched
Control 47.7  7.3c 29.8  2.9c,d 21.3  5.8d 80 (40.7) 64.7  4.8c 84.7  2.0a,d 128.2  4.1a,e
DEX 58.8  9.8c 24.3  6.3d 16.7  6.7e 69 (34.5) 74.0  2.3a 117.6  3.4b,d 153.7  9.7b,e
The results are average of at least ﬁve independent experiments.
a,b Different superscript letters denote signiﬁcant differences (P < 0.05) within column.
c,d Different superscript letters denote signiﬁcant differences (P < 0.05) within row.
Abbreviations: DEX, dexamethasone; SEM, standard error of the mean.
e Percentage based on the total number of blastocysts.
f Percentage based on the total number of oocytes inseminated.
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DEX has been shown to inhibit apoptosis in some somatic
cell systems [19–21], we hypothesized that DEX supple-
mentation during IVC would have a positive impact on
embryo development. However, although DEX treatment
had no quantitative effect on cleavage/blastocyst or
apoptosis rates, treatment improved developmental ki-
netics and increased the number of cells both on Days 4 and
7, suggesting some positive effects of DEX on cell prolifera-
tion. In agreement, recent studies on ﬁsh embryos have
shown similar positive effects of GCs via the expression
enhancement of IGF-related growth factor genes [38,39].
Additionally, fasted rats displayed stress-induced plasma
increases in GC concentrations that correlated with in-
creases in the expression of the cell cycle regulationproteins
p21 and cyclin D1 in gastric and intestinal mucosa, sup-
porting another possible mechanism by which GCs may
induce cell proliferation [13]. Interestingly, the GC receptors
that are speculated to mediate DEX effects in somatic cell
studies are also expressed in bovine embryos from Day 2 of
development [40]. In this regard, we speculate that the
stressful condition of embryo culture in itself [41] may
facilitate the effects of DEX on cell proliferation via both
genomic and nongenomic mechanisms. In support of this
hypothesis, previous studies have shown that DEX can bind
stress-activated GC receptors in mitochondria thereby
regulating themembranepotential in hippocampal neuronsFig. 1. Effect of in vitro culture medium containing 0.1 mg/mL dexametha-
sone upon the developmental kinetics of early bovine embryos. Slow-
cleaving embryos (black bar) displayed less than 12 cells. Fast-cleaving
embryos (white bar) displayed more than 13 cells. *denotes a signiﬁcant
difference (P  0.05).[42]. This may also result in GC-driven upregulation of en-
ergy metabolism [43,44], which in turn is essential in
driving cell proliferation in mammalian embryos [45].
Considering the wide range of effects reported for GCs on
somatic cells, future studies may be aimed at analyzing the
mechanisms involved in DEX-induced cell proliferation of
IVC embryos.Moreover, the above reported ﬁndings beg the
question of whether stressing IVF-produced zygotes before
IVC may allow DEX treatment to further exert a positive
effect on development.
Given the reported antiapoptotic effects of DEX in so-
matic cell culture, we hypothesized that its addition to the
IVC system would reduce apoptotic rates in in vitro–pro-
duced bovine embryos. However, rates of apoptosis were
similar between untreated and treated embryos. Worth
noting is that the rates of apoptosis shown herein were
similar to those previously reported, which, in turn, were
highly correlated to the stage of embryo development
[7,8,34,46]. In fact, apoptosis as assessed via TUNEL assay
was ﬁrst detected in 30% to 50% of in vitro–produced em-
bryos just after the eight- to 16-cell stage [34]. Herein, using
a different apoptotic marker (annexin V), we observed
similar rates (w30%) at the same stage of development, thus
corroborating the occurrence of apoptosis during early
in vitro embryo development in bovine embryos.
Conversely, however, apoptosis as detected by TUNEL
occurred as early as the four-cell stage in SCNT bovine em-
bryos. Moreover, such embryos displayed higher apoptosis
rates throughout all stages of development as compared
with IVF embryos [6,8]. Thus, future studies should also test
the effects of DEX treatment on SCNTembryo development.
One additional consideration is that of how early em-
bryo apoptosis may affect their further developmental
potential [33,34]. To some extent, apoptosis may beTable 4
Effect of addition of 0.1 mg/mL dexamethasone (DEX) to the IVC medium
on the development kinetics and apoptosis rates of Day 4 bovine embryos.
Group Slow Fast Total
na Apoptoticb na Apoptoticb na Apoptoticb
Control 16 31 (5/16) 5 20 (1/5) 21 28 (6/21)
DEX 5 40 (2/5) 9 22 (2/9) 14 28 (4/14)
The results are average of at least ﬁve independent experiments.
No difference was found between the experimental groups (P  0.05; c2
test).
Abbreviation: DEX, dexamethasone.
a Number of embryos analyzed at each experimental group.
b Percentage of embryos containing at least one apoptotic blastomere.
Table 5
Addition of 0.1 mg/mL dexamethasone to the IVC medium on the total
number of cells and number of apoptotic blastomeres of Day 4 bovine
embryos.
Groupa Control (mean  SEM) DEX (mean  SEM)
Slow Fast Slow Fast
No. of cells 7.4  0.7b,d 13  0.4b,e 6.4  1.3b,d 16.4  1.2b,e
Apoptotic 1.1  0.1c 2.0  0.5c 1.5  0.5c 2.0  0.0c
The results are average of at least ﬁve independent experiments.
b,c Different superscript letters denote signiﬁcant differences (P  0.05)
within column.
d,e Different superscript letters denote signiﬁcant differences (P  0.05)
within row.
Abbreviations: DEX, dexamethasone; SEM, standard error of the mean.
a Number of apoptotic blastomeres in each embryo.
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cells which could otherwise impair later embryo develop-
ment [1], that is, as long as remaining cells would be able to
compensate for cells lost early in the cleavage process
[2,47]. Therefore, high rates of apoptosis in the early em-
bryo are also related to embryo losses, a fairly frequent
occurrence in mammals which is typically manifested as
infertility [48,49]. Notably, although apoptosis was detec-
ted in early stages of embryo development in our study, no
adverse outcome was observed in regards to blastocyst
rates on Day 7 of IVC, with or without DEX treatment. This
ﬁnding is consistent with early apoptosis not impairing
later embryo development. Moreover, previous ﬁndingsFig. 2. Representative images of early (Day 4) bovine embryos cultured with or
increased the percentage of fast-cleaving embryos (C, D, E, F) in comparison to th
apoptotic (C, D). Embryos were considered apoptotic if they had at least one blastom
arrow), propidium iodide (image not shown), or with annexin plus propidium iodid
C, E), and epiﬂuorescence counterstained with the nuclear dye Hoechst 33342 (B,support the notion of apoptosis being a potentially
reversible process, at least up to a certain threshold;
however, neither this threshold nor the reversibility
mechanism has been elucidated [50,51]. Notably, an SCNT
pregnancy was obtained through the use of annexin V-
positive bovine ﬁbroblasts suggesting that the apoptotic
stimulus initiated in the donor cell was reversed within the
oocyte’s cytoplasm, hence resulting in competent embryos.
However, not all annexin V-positive cells yielded embryos,
suggesting a heterogeneity in the apoptotic process among
cells [52]. In fact, annexin V binding to detect phosphati-
dylserine externalization is generally considered a very
sensitive detection method of irreversible early apoptosis
[53]. However, in this study, Day 4 apoptotic embryos
treated with DEX developed to Day 7 with higher cell
numbers as compared with untreated embryos. Hence,
whether apoptosis was reversed in such embryos, or DEX
simply compensated for this process by increasing cell
proliferation is unclear. To further investigate these as-
sumptions, embryos with or without apoptotic cells should
be cultured separately in the presence or absence of DEX
and followed through until Day 7 of development.
4.1. Conclusions
In summary, our results are consistent with DEX having
a positive impact on bovine embryo developmental ki-
netics through increased cell proliferation rather thanwithout 0.1 mg/mL dexamethasone (DEX)-containing medium. Treatment
e untreated control group (A, B). Unstained embryos were considered non-
ere stained with annexin (B, F; green color in the web version indicated by
e (F; orange color in the web version indicated by arrowhead). Brightﬁeld (A,
D, F, corresponding to A, C, E, respectively). 200X magniﬁcation.
P.P.B. Santana et al. / Theriogenology 82 (2014) 10–16 15inhibiting apoptosis itself. Further studies should be un-
dertaken to investigate the effect of GCs on the cell cycle
and mechanisms of cell proliferation in mammalian em-
bryos at the preimplantation stage.
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